193
Views
0
CrossRef citations to date
0
Altmetric
Commentary

How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?

&
Pages 3283-3286 | Received 06 Oct 2020, Accepted 09 Oct 2020, Published online: 04 Nov 2020
 

Disclosure statement

Dr. Flowers was an investigator on GO29365. No potential conflict of interest was reported by the author(s).

Additional information

Funding

CRF is the CPRIT Scholar of Cancer Research. The project described was supported in part by CRF's K24 CA208132 award for mentored patient-oriented research in lymphoma from the National Cancer Institute and CPRIT Award RR190079. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.